Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,097 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I.
Tsuji D, Nakagaki S, Yonezawa I, Suzuki K, Yokokawa T, Kawasaki Y, Yamaguchi T, Kawaguchi T, Hatori M, Matsumoto T, Sakata Y, Yamamoto K, Nishimura T, Kogure Y, Hayashi T, Osawa M, Itoh K, Watanabe M. Tsuji D, et al. Among authors: sakata y. Invest New Drugs. 2024 Feb;42(1):44-52. doi: 10.1007/s10637-023-01414-y. Epub 2023 Dec 6. Invest New Drugs. 2024. PMID: 38055127 Clinical Trial.
Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial.
Abe M, Yamaguchi T, Fujita Y, Nishimura T, Kitagawa K, Inui N, Hirano K, Sakata Y, Iihara H, Shibuya Y, Suzuki K, Shibata K, Hori K, Daga H, Nakayama T, Sakata Y, Takahashi TY, Zenda S, Hashimoto H. Abe M, et al. Among authors: sakata y. JAMA Netw Open. 2023 May 1;6(5):e2310894. doi: 10.1001/jamanetworkopen.2023.10894. JAMA Netw Open. 2023. PMID: 37129897 Free PMC article. Clinical Trial.
Appropriate Selection of Substrate Ablation for Persistent Atrial Fibrillation Using Intraprocedural Assessment.
Matsunaga-Lee Y, Inoue K, Tanaka N, Masuda M, Watanabe T, Makino N, Egami Y, Oka T, Minamiguchi H, Miyoshi M, Okada M, Kanda T, Matsuda Y, Kawasaki M, Kawanami S, Sugae H, Ukita K, Kawamura A, Yasumoto K, Tsuda M, Okamoto N, Yano M, Nishino M, Sunaga A, Sotomi Y, Dohi T, Nakatani D, Hikoso S, Sakata Y; Osaka Cardiovascular Conference (OCVC) Arrhythmia Investigators. Matsunaga-Lee Y, et al. Among authors: sakata y. Circ J. 2024 May 30. doi: 10.1253/circj.CJ-23-0936. Online ahead of print. Circ J. 2024. PMID: 38811199
Anomalous Left Atrial Band With Atrial Septal Defect.
Kosugi S, Mizote I, Nakamura D, Miyagawa S, Sakata Y. Kosugi S, et al. Among authors: sakata y. Circ J. 2024 May 21. doi: 10.1253/circj.CJ-24-0305. Online ahead of print. Circ J. 2024. PMID: 38777766 Free article. No abstract available.
Characteristic craniofacial defects associated with a novel USP9X truncation mutation.
Nagata N, Kurosaka H, Higashi K, Yamaguchi M, Yamamoto S, Inubushi T, Nagata M, Ishihara Y, Yonei A, Miyashita Y, Asano Y, Sakai N, Sakata Y, Kawabata S, Yamashiro T. Nagata N, et al. Among authors: sakata y. Hum Genome Var. 2024 May 16;11(1):21. doi: 10.1038/s41439-024-00277-w. Hum Genome Var. 2024. PMID: 38755172 Free PMC article.
Rationale and Design of Prospective, Multicenter, Double-Arm Clinical Trial to Investigate the Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus (TOP-HFPEF Trial).
Ito S, Nakajima Y, Fukuda H, Izumi C, Nakazawa G, Yamashita H, Matsuhisa H, Inoko M, Toyoda S, Takiuchi S, Kataoka T, Izumiya Y, Abe Y, Sozu T, Sakata Y, Emoto M, Inoue T, Kitakaze M. Ito S, et al. Among authors: sakata y. Cardiovasc Drugs Ther. 2024 May 10. doi: 10.1007/s10557-024-07576-y. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 38727896
2,097 results